Navigation Links
Intravenous Equipment - Global Strategic Business Report
Date:11/20/2013

Covered:


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

2. MARKET PULSE

3. INDUSTRY ISSUES

4. TECHNOLOGY/PRODUCT BREAK THROUGHS

5. PRODUCT OVERVIEW

6. RAW MATERIAL OVERVIEW

7. PRODUCT INNOVATIONS/INTRODUCTIONS

8. RECENT INDUSTRY ACTIVITY

9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER

10. FOCUS ON SELECT PLAYERS

11. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. CANADA

3. JAPAN

4. EUROPE

4a. FRANCE

4b. GERMANY

4c. ITALY

4d. THE UNITED KINGDOM

4e. REST OF EUROPE

5. ASIA-PACIFIC

6. LATIN AMERICA

7. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Companies Mentioned

- Access Scientific, Inc. (USA)
- Arrow International, Inc. (USA)
- Ascor SA (Poland)
- Baxter International, Inc. (USA)
- Baxter Healthcare Corporation (USA)A)
- Breg, Inc. (USA)
- Briggs Corporation (USA)
- Daiwha Corporation Ltd. (Korea)
- Infus Medical Co., Ltd. (Thailand)
- Medcomp®-Medical Components, Inc. (USA)
- RMS Medical Products (USA)
- Samtronic Industria E Comercio Ltd. (Brazil)
-
'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. 2013 China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report
2. Systematic Review Finds Intranasal Midazolam Comparable To Intravenous Or Rectal Administration Of Diazepam For Treatment Of Acute Seizure Emergencies In Pediatric Patients
3. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
4. Global Intravenous Solutions (Parenteral Nutrition) Industry
5. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
6. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
7. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
8. Physician-Patient Alliance for Health & Safety Announces New Expert Checklist for Facilitating Safety of Hospital-Based Intravenous Patient-Controlled Analgesia Pumps
9. Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017: Transparency Market Research
10. Wholesale Supplier Sarah Medic Provides Vast Inventory of Quality Medical Equipment and Exceptional Customer Service
11. China Pharmaceutical Equipment Industry Report, 2012-2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... WORTH, Texas , April 27, 2015 ... market is segmented based on type, application, and geography and ... at $728.9 million in 2014, and is expected to reach ... the forecast period. Browse through the TOC of ... idea of the in-depth analysis provided. This also provides a ...
(Date:4/27/2015)... April 27, 2015  Eiger BioPharmaceuticals, Incorporated today announced ... of lonafarnib in patients with chronic hepatitis delta viral ... program, enrolled at Ankara University Medical School, ... endemic. LOWR HDV - 1 (LOnafarnib ... study which randomized subjects to receive different doses of ...
(Date:4/27/2015)... NEW YORK , April 27, 2015 /PRNewswire/ ... market for electronic medical records (EMR) to grow ... for US healthcare providers, according to a recent ... system upgrades, international sales and continued efficiency improvements ... each year for the next five years.  The ...
Breaking Medicine Technology:North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 2North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 3Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3Kalorama: EMR Market Expected To Grow Beyond Incentives 2Kalorama: EMR Market Expected To Grow Beyond Incentives 3
... , WALTHAM, Mass., Dec. 15 Decision Resources, one of ... healthcare issues, finds that an overall survival benefit would be ... in their decision to prescribe a novel agent ahead of ... Special European Physician & Payer Forum report entitled European ...
... BEND, Oregon, December 15 Bend Research Inc. ... for HPMCAS, an,excipient used in technologies developed by the firm to ... Bend Research clients may now reference a Type V Drug ... Research officials said. , "We,re excited about ...
Cached Medicine Technology:For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2
(Date:4/27/2015)... April 27, 2015 Array Health ... technology, has announced that Lance Hood, senior director of ... fourth annual Direct-to-Consumer Health Care Marketing Summit ... David Smith, Partner and Director of Payer Services, Leavitt ... care consumerism – through a retail/e-commerce perspective – and ...
(Date:4/27/2015)... April 27, 2015 Ticket Down is a ... Philadelphia for his upcoming concert on Sunday, June 21st. ... thrill his countless North American fans again in 2015 when ... his "Out There" tour. He will be performing in ... to listen to this legendary performer for the first time ...
(Date:4/27/2015)... Thanks to a $7.5 million grant ... half-dozen institutions, including American University, will operate in a ... and behavioral research aimed at ending the AIDS epidemic. ... with HIV or AIDS, according to the latest statistics. ... population over the age of 13 was living with ...
(Date:4/27/2015)... Angeles, CA (PRWEB) April 27, 2015 The ... has been to connect clients of personal injury attorneys with ... network of doctors has seen steady growth throughout their history ... Charles E. Richardson, DC and his team in the ... including a medical doctor and massage therapist, patients can find ...
(Date:4/27/2015)... April 27, 2015 Sitting or standing for ... and feel tired, and for those whose occupation requires them ... and taxi cab drivers, or to be on their feet ... the discomfort can be more severe and longer lasting. These ... syndrome. Dr. Madaiah Revana of Northeast Houston Vein Center is ...
Breaking Medicine News(10 mins):Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2Health News:Paul McCartney Presale Tickets at Wells Fargo Center in Philadelphia: Ticket Down Slashes Paul McCartney Ticket Prices in Philadelphia at the Wells Fargo Center 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3
... Feb. 26 AIDS Action congratulates Jeffrey Crowley, an ... health care and HIV/AIDS for his appointment as Director ... He joins a well-respected and dedicated team in the ... and reports to Director Melody Barnes who has a ...
... inhibit both normal and virulent strains, study finds ... Combination treatment with two FDA-approved drugs shows promise ... study shows. , In laboratory tests, researchers at ... National Institute of Allergy and Infectious Diseases found ...
... The number of Americans traveling abroad for healthcare is ... trend as the recession worsens and more Americans are left ... to the Deloitte Centre for Health Solutions, the number of ... million in 2010 and 15.75 million by 2017. The $16 ...
... Ignagni, President and CEO of America,s Health Insurance Plans, ... President,s budget:"Today,s budget submission sends a signal to the ... health care. We applaud the President for laying ... to put our nation on a path towards comprehensive ...
... Consultancy, is pleased to announce the launch of a further nine ... listings to relevant specialist industries. , ... (PRWEB) February ... & Marketing Consultancy , is pleased to announce the launch of ...
... RALEIGH, N.C., Feb. 26 Arbor Pharmaceuticals, a ... that the company has launched XYLAREX - a ... otitis media (middle ear,infections). XYLAREX is a ... reduce the number of ear infections children experience. ...
Cached Medicine News:Health News:AIDS Action Applauds President on Appointment of Jeffrey Crowley as Director of National AIDS Policy 2Health News:Antibiotic Combo Fights Resistant TB 2Health News:Americans Will Soon Have Medical Butlers to Assist in Medical Tourism Research 2Health News:AHIP Statement on the President's Budget 2Health News:Simply Marcomms Launch New Specialist Online Industry Directories 2Health News:Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children 2
Mayfield Disposable Adult (plastic) Skull Pins are designed for rigid skeletal fixation....
Endoscopes...
Short system ventriculoscope for free hand use....
Preclude Dura Substitute is the only non-biological membrane designed to "seal" around suture holes. 0.3 mm as nominal thickness....
Medicine Products: